 |
At a Glance*
(dollars in thousands) |
|
| Fiscal Year 2007 Estimate |
$4,696,227 |
| Current Services Increase |
282,998 |
| |
Subtotal |
$4,979,225 |
| Fiscal Year 2008 Additional
Resources |
| |
Increase Success Rate for Research Project Grants |
277,000 |
| |
Expanding Cancer Center Research |
77,000 |
| |
Linking Science and Technology |
170,000 |
| |
Integrating Science through Interdisciplinary Teams |
196,000 |
| |
Cancer Clinical Trials |
100,000 |
| |
Subtotal |
$820,000 |
| Total
NCI |
$5,799,225 |
| *
Does not include the NCI contribution to the NIH
Roadmap. |
|
|
|
| The
NIH Budget and the Future of Biomedical Research - content.nejm.org
Joseph Loscalzo, M.D., Ph.D.
Whatever mechanisms are ultimately chosen, it seems clear that
new methods of support must be developed if biomedical research
is to continue to thrive in the United States. The goal of a
durable, steady stream of support for research in the life
sciences has never been more pressing, since the research
derived from that support has never promised greater benefits.
The fate of life-sciences research should not be consigned to
the political winds of Washington.
|
| Projecting Future Drug Expenditures--2004 - Medscape
(free login req.)
|
| Hidden drug-re-import
potential (commentary) - Washington
Times
|
| Clinical Research "Undernourished" in U.S. Health System -
Medscape 2004 (free login req.)
|
| Clinical Trials Cost No More Than Standard Care 2000/05/26 -
ACS
|
| New
Medicare policy will deny access to novel therapies,
including treatments
that win approval based on surrogate endpoints.
Click here to act
|
|
|
|
|
